sj-jpg-2-jop-10.1177_02698811211069108 – Supplemental material for Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial

  • M Axel Wollmer (Scientific Creator)
  • Insa Neumann (Scientific Creator)
  • Stefanie Jung (Scientific Creator)
  • Agnès Bechinie (Scientific Creator)
  • Julian Herrmann (Scientific Creator)
  • Antje Müller (Scientific Creator)
  • Peter Wohlmuth (Scientific Creator)
  • Larissa Fournier-Kaiser (Scientific Creator)
  • Christian Sperling (Scientific Creator)
  • Liza Peters (Scientific Creator)
  • Jonas Kneer (Scientific Creator)
  • Jannis Engel (Scientific Creator)
  • Frank Jürgensen (Scientific Creator)
  • Jara Schulze (Scientific Creator)
  • Matthias Nagel (Department of Psychiatry and Psychotherapy, Asklepios Clinic North – Wandsbek, Asklepios Clinic Nord-Wandsbek, Department of Psychiatry and Psychotherapy) (Scientific Creator)
  • Welf Prager (Scientific Creator)
  • Christopher Sinke (Scientific Creator)
  • Kai G Kahl (Hannover Medical School) (Scientific Creator)
  • Matthias Karst (Scientific Creator)
  • Birger Dulz (Scientific Creator)
  • Tillmann H. Krüger (Scientific Creator)

Dataset

Description

Supplemental material, sj-jpg-2-jop-10.1177_02698811211069108 for Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial by M Axel Wollmer, Insa Neumann, Stefanie Jung, Agnès Bechinie, Julian Herrmann, Antje Müller, Peter Wohlmuth, Larissa Fournier-Kaiser, Christian Sperling, Liza Peters, Jonas Kneer, Jannis Engel, Frank Jürgensen, Jara Schulze, Matthias Nagel, Welf Prager, Christopher Sinke, Kai G Kahl, Matthias Karst, Birger Dulz and Tillmann H C Kruger in Journal of Psychopharmacology
Date made available2022
PublisherSAGE Journals

Cite this